Analytical Data
-
Gene name
C9orf103
- Application
-
Alternative Names
C9orf103；C9orf103；Probable gluconokinase
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5T6J7
-
Expression Region
1-187aa
-
AA Sequence
MAAPGALLVM GVSGSGKSTV GALLASELGW KFYDADDYHP EENRRKMGKG IPLNDQDRIP WLCNLHDILL RDVASGQRVV LACSALKKTY RDILTQGKDG VALKCEESGK EAKQAEMQLL VVHLSGSFEV ISGRLLKREG HFMPPELLQS QFETLEPPAA PENFIQISVD KNVSEIIATI METLKMK
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C9orf103, or chromosome 9 open reading frame 103, is a gene of significant interest in recent biomedical research due to its potential involvement in various neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). This gene has garnered attention primarily because of its association with disease-causing genetic mutations and its potential role in inflammatory responses within the nervous system. Studies have shown that the protein encoded by C9orf103 may modulate immune responses and could interact with other key proteins involved in neuroinflammation and neuronal survival. The recombinant protein of C9orf103 provides a valuable tool for scientists to study its functional properties, interactions, and the underlying mechanisms through which it may influence disease pathology. Understanding the biochemical characteristics and biological roles of C9orf103 may lead to the identification of novel therapeutic targets and biomarkers for early detection of neurodegenerative disorders. Furthermore, the investigation of C9orf103's protein structure and function could enhance our comprehension of the pathophysiological processes relevant to ALS and FTD, paving the way for innovative treatments that aim to mitigate the effects of these debilitating diseases. Overall, the research surrounding C9orf103 and its recombinant protein is critical for elucidating the complexities of neurodegeneration and holds promise for advancing therapeutic approaches in the field of neurology.
